🇺🇸 Androgen Therapy in United States
6 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 6
Most-reported reactions
- Blood Testosterone Decreased — 1 report (16.67%)
- Bone Pain — 1 report (16.67%)
- Hypophagia — 1 report (16.67%)
- Lymphadenopathy — 1 report (16.67%)
- Metastases To Bone — 1 report (16.67%)
- Prostatic Specific Antigen Increased — 1 report (16.67%)
Other Oncology approved in United States
Frequently asked questions
Is Androgen Therapy approved in United States?
Androgen Therapy does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Androgen Therapy in United States?
Alliance for Clinical Trials in Oncology is the originator. The local marketing authorisation holder may differ — check the official source linked above.